Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia

Background. Autoimmune polyglandular syndrome type 1 (APS type 1) is a rare inherited autoimmune disease caused by mutations in AIRE gene (autoimmune regulator) and characterized by list of components. Diabetes mellitus (DM) can be one of components of this disease. Aims. To show frequency of DM in...

Full description

Bibliographic Details
Main Authors: Leila S. Sozaeva, Lubov I. Zilberman, Galina N. Svetlova, Ekaterina A. Andrianova, Maria A. Kareva, Olga N. Ivanova, Svetlana M. Stepanova, Larisa V. Savelyeva, Alexandr Y. Mayorov, Ekaterina A. Troshina, Elizaveta M. Orlova, Eystein S. Husebye, Valentina A. Peterkova
Format: Article
Language:English
Published: Endocrinology Research Centre 2018-03-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/9347
_version_ 1797255173880414208
author Leila S. Sozaeva
Lubov I. Zilberman
Galina N. Svetlova
Ekaterina A. Andrianova
Maria A. Kareva
Olga N. Ivanova
Svetlana M. Stepanova
Larisa V. Savelyeva
Alexandr Y. Mayorov
Ekaterina A. Troshina
Elizaveta M. Orlova
Eystein S. Husebye
Valentina A. Peterkova
author_facet Leila S. Sozaeva
Lubov I. Zilberman
Galina N. Svetlova
Ekaterina A. Andrianova
Maria A. Kareva
Olga N. Ivanova
Svetlana M. Stepanova
Larisa V. Savelyeva
Alexandr Y. Mayorov
Ekaterina A. Troshina
Elizaveta M. Orlova
Eystein S. Husebye
Valentina A. Peterkova
author_sort Leila S. Sozaeva
collection DOAJ
description Background. Autoimmune polyglandular syndrome type 1 (APS type 1) is a rare inherited autoimmune disease caused by mutations in AIRE gene (autoimmune regulator) and characterized by list of components. Diabetes mellitus (DM) can be one of components of this disease. Aims. To show frequency of DM in patients with APS type 1 in Russia, to describe clinical and immunological aspects of DM in patients with APS type 1 Materials and methods. 113 patients have been enrolled in the study, 16 of them had DM (15/16) or impaired glucose tolerance (1/16). Antibodies against glutamate decarboxylase, tyrosine phosphatase, zinc transporter-8, insulin and β-cells of pancreas were investigated in 30 patients with APS type 1 without DM and in 11 patients with APS type 1 and DM. ELISA test was used for detection autoantibodies. Results. Frequency of DM in patients with APS type 1 in Russia is 14.1% (16/113). Some patients had slow-progressive DM – 19%(3/16). Antibodies against insulin and β-cells were not specific and also were not sensitive markers for DM in APS type 1. Antibodies against tyrosine phosphatase and zinc transporter-8 test showed high specificity (100% и 97%), but low sensitivity (42% и 33,3%). Antibodies against glutamate decarboxylase were less specific (70%) and had very low sensitivity (58,3%). Conclusions. Frequency of DM in patients with APS type 1 in Russia is high to compare to other countries. 20% of Russian patients had slow-progressive course of DM. Antibodies against tyrosine phosphatase and zinc transporter-8 were the most specific for DM in patients with APS type 1, but sensitivity of these antibodies was low.
first_indexed 2024-03-08T15:20:41Z
format Article
id doaj.art-d65b388c5d854351b4a44c51cabd9441
institution Directory Open Access Journal
issn 2072-0351
2072-0378
language English
last_indexed 2024-04-24T22:01:39Z
publishDate 2018-03-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj.art-d65b388c5d854351b4a44c51cabd94412024-03-20T11:48:01ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782018-03-01211485710.14341/DM93478429Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in RussiaLeila S. Sozaeva0Lubov I. Zilberman1Galina N. Svetlova2Ekaterina A. Andrianova3Maria A. Kareva4Olga N. Ivanova5Svetlana M. Stepanova6Larisa V. Savelyeva7Alexandr Y. Mayorov8Ekaterina A. Troshina9Elizaveta M. Orlova10Eystein S. Husebye11Valentina A. Peterkova12<p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>University of Bergen</p><p>Endocrinology Research Centre</p>Background. Autoimmune polyglandular syndrome type 1 (APS type 1) is a rare inherited autoimmune disease caused by mutations in AIRE gene (autoimmune regulator) and characterized by list of components. Diabetes mellitus (DM) can be one of components of this disease. Aims. To show frequency of DM in patients with APS type 1 in Russia, to describe clinical and immunological aspects of DM in patients with APS type 1 Materials and methods. 113 patients have been enrolled in the study, 16 of them had DM (15/16) or impaired glucose tolerance (1/16). Antibodies against glutamate decarboxylase, tyrosine phosphatase, zinc transporter-8, insulin and &beta;-cells of pancreas were investigated in 30 patients with APS type 1 without DM and in 11 patients with APS type 1 and DM. ELISA test was used for detection autoantibodies. Results. Frequency of DM in patients with APS type 1 in Russia is 14.1% (16/113). Some patients had slow-progressive DM &ndash; 19%(3/16). Antibodies against insulin and &beta;-cells were not specific and also were not sensitive markers for DM in APS type 1. Antibodies against tyrosine phosphatase and zinc transporter-8 test showed high specificity (100% и 97%), but low sensitivity (42% и 33,3%). Antibodies against glutamate decarboxylase were less specific (70%) and had very low sensitivity (58,3%). Conclusions. Frequency of DM in patients with APS type 1 in Russia is high to compare to other countries. 20% of Russian patients had slow-progressive course of DM. Antibodies against tyrosine phosphatase and zinc transporter-8 were the most specific for DM in patients with APS type 1, but sensitivity of these antibodies was low.https://www.dia-endojournals.ru/jour/article/view/9347autoimmune polyglandular syndrome type 1airediabetes mellitusantibodiesglutamate decarboxylasetyrosine phosphatasezinc transporter-8insulinβ-cells of pancreas
spellingShingle Leila S. Sozaeva
Lubov I. Zilberman
Galina N. Svetlova
Ekaterina A. Andrianova
Maria A. Kareva
Olga N. Ivanova
Svetlana M. Stepanova
Larisa V. Savelyeva
Alexandr Y. Mayorov
Ekaterina A. Troshina
Elizaveta M. Orlova
Eystein S. Husebye
Valentina A. Peterkova
Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia
Сахарный диабет
autoimmune polyglandular syndrome type 1
aire
diabetes mellitus
antibodies
glutamate decarboxylase
tyrosine phosphatase
zinc transporter-8
insulin
β-cells of pancreas
title Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia
title_full Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia
title_fullStr Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia
title_full_unstemmed Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia
title_short Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia
title_sort clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in russia
topic autoimmune polyglandular syndrome type 1
aire
diabetes mellitus
antibodies
glutamate decarboxylase
tyrosine phosphatase
zinc transporter-8
insulin
β-cells of pancreas
url https://www.dia-endojournals.ru/jour/article/view/9347
work_keys_str_mv AT leilassozaeva clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT lubovizilberman clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT galinansvetlova clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT ekaterinaaandrianova clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT mariaakareva clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT olganivanova clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT svetlanamstepanova clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT larisavsavelyeva clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT alexandrymayorov clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT ekaterinaatroshina clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT elizavetamorlova clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT eysteinshusebye clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia
AT valentinaapeterkova clinicalandimmunologicalcharacteristicsofdiabetesmellitusinpatientswithautoimmunepolyglandularsyndrometype1inrussia